<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="13/07/2006" creator="Yo Shidahara" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8018594">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8018594</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Effects of <term sem="Lipid" id="T1" lex="prostaglandin_E2">prostaglandin E2</term> on <term sem="Cell_cultured" id="T2" lex="Th0-type_human_T_cell_clone">Th0-type human T cell clones</term>: modulation of functions of <term sem="Protein_family_or_group" id="T3" lex="nuclear_protein">nuclear proteins</term> involved in <term sem="Other" id="T4" lex="cytokine_production"><term sem="Protein_family_or_group" id="T5" lex="cytokine">cytokine</term> production</term>.</sentence>
<event id="E1">
<type class="Regulation" />
<cause idref="T1" />
<clue><clueType>Effects</clueType> <linkCause>of</linkCause> prostaglandin E2 <clueLoc>on Th0-type human T cell clones</clueLoc>: modulation of functions of nuclear proteins involved in cytokine production.</clue>
<comment>NER T1 MOD</comment>
</event>
<event id="E2">
<type class="Regulation" />
<theme idref="T3" />
<cause idref="T1" />
<clue>Effects of prostaglandin E2 on Th0-type human T cell clones: <clueType>modulation</clueType> <linkTheme>of</linkTheme> functions of nuclear proteins involved in cytokine production.</clue>
</event>
<event id="E3">
<type class="Gene_expression" />
<theme idref="T5" />
<clue>Effects of prostaglandin E2 on Th0-type human T cell clones: modulation of functions of nuclear proteins involved in cytokine <clueType>production</clueType>.</clue>
</event>
<event id="E4">
<type class="Correlation" />
<theme idref="T3" />
<theme idref="E3" />
<clue>Effects of prostaglandin E2 on Th0-type human T cell clones: modulation of functions of nuclear proteins <clueType>involved</clueType> <linkTheme>in</linkTheme> cytokine production.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The effects of <term sem="Lipid" id="T6" lex="prostaglandin_E2">prostaglandin E2</term> (<term sem="Lipid" id="T7" lex="PGE2">PGE2</term>) on <term sem="Other" id="T8" lex="cytokine_production"><term sem="Protein_family_or_group" id="T9" lex="cytokine">cytokine</term> production</term> and <term sem="Other" id="T10" lex="proliferation">proliferation</term> of the <term sem="Cell_cultured" id="T11" lex="CD4+_human_helper_T_cell_clone_SP-B21">CD4+ human helper T cell clone SP-B21</term> were investigated.</sentence>
<event id="E5">
<type class="Gene_expression" />
<theme idref="T9" />
<clue>The effects of prostaglandin E2 (PGE2) on cytokine <clueType>production</clueType> and proliferation of the CD4+ human helper T cell clone SP-B21 were investigated.</clue>
<comment>NER T6,T7 MOD</comment>
</event>
<event uncertainty="doubtful" id="E6">
<type class="Regulation" />
<theme idref="E5" />
<cause idref="T7" />
<clue>The <clueType>effects</clueType> <linkCause>of</linkCause> prostaglandin E2 (PGE2) <linkTheme>on</linkTheme> cytokine production and proliferation of the CD4+ human helper T cell clone SP-B21 were investigated.</clue>
</event>
<event id="E7">
<type class="Cellular_physiological_process" />
<theme idref="T11" />
<clue>The effects of prostaglandin E2 (PGE2) on cytokine production and <clueType>proliferation</clueType> <linkTheme>of</linkTheme> the CD4+ human helper T cell clone SP-B21 were investigated.</clue>
</event>
<event uncertainty="doubtful" id="E8">
<type class="Regulation" />
<theme idref="E7" />
<cause idref="T7" />
<clue>The <clueType>effects</clueType> <linkCause>of</linkCause> prostaglandin E2 (PGE2) <linkTheme>on</linkTheme> cytokine production and proliferation of the CD4+ human helper T cell clone SP-B21 were investigated.</clue>
</event>
<sentence id="S3">In <term sem="Cell_natural" id="A1">cells</term> stimulated with <term sem="Protein_molecule" id="T12" lex="anti-CD3_mAb">anti-CD3 mAb</term>, <term sem="Lipid" id="T13" lex="PGE2">PGE2</term> inhibited <term sem="Other" id="T14" lex="cell_proliferation">cell proliferation</term> and the production of all the <term sem="Protein_family_or_group" id="T15" lex="cytokine">cytokines</term> examined.</sentence>
<event id="E9">
<type class="Negative_regulation" />
<theme idref="T14" />
<cause idref="T13" />
<clue><clueLoc>In cells stimulated with anti-CD3 mAb</clueLoc>, PGE2 <clueType>inhibited</clueType> cell proliferation and the production of all the cytokines examined.</clue>
<comment>NER T13 MOD</comment>
</event>
<event id="E10">
<type class="Gene_expression" />
<theme idref="T15" />
<clue>In cells stimulated with anti-CD3 mAb, PGE2 inhibited cell proliferation and the <clueType>production</clueType> <linkTheme>of</linkTheme> all the cytokines examined.</clue>
</event>
<event id="E11">
<type class="Negative_regulation" />
<theme idref="E10" />
<cause idref="T13" />
<clue><clueLoc>In cells stimulated with anti-CD3 mAb</clueLoc>, PGE2 <clueType>inhibited</clueType> cell proliferation and the production of all the cytokines examined.</clue>
</event>
<event id="E12">
<type class="Physiological_process" />
<theme idref="A1" />
<cause idref="T12" />
<clue>In cells <clueType>stimulated</clueType> <linkCause>with</linkCause> anti-CD3 mAb, PGE2 inhibited cell proliferation and the production of all the cytokines examined.</clue>
</event>
<sentence id="S4">Addition of <term sem="Protein_molecule" id="T16" lex="rIL-2">rIL-2</term> fully restored the proliferative response and partially restored the production of <term sem="Protein_molecule" id="T17" lex="IL-4">IL-4</term> and <term sem="Protein_molecule" id="T18" lex="IL-5">IL-5</term>, but not that of <term sem="Protein_family_or_group" id="T19" lex="cytokine">other cytokines</term>.</sentence>
<event id="E14">
<type class="Negative_regulation" />
<theme idref="E11" />
<cause idref="T16" />
<clue><linkCause>Addition of</linkCause> rIL-2 fully <clueType>restored</clueType> <corefTheme>the proliferative response</corefTheme> and partially restored the production of IL-4 and IL-5, but not that of other cytokines.</clue>
</event>
<event id="E15">
<type class="Gene_expression" />
<theme idref="T17" />
<clue>Addition of rIL-2 fully restored the proliferative response and partially restored the <clueType>production</clueType> <linkTheme>of</linkTheme> IL-4 and IL-5, but not that of other cytokines.</clue>
</event>
<event id="E16">
<type class="Gene_expression" />
<theme idref="T18" />
<clue>Addition of rIL-2 fully restored the proliferative response and partially restored the <clueType>production</clueType> <linkTheme>of</linkTheme> IL-4 and IL-5, but not that of other cytokines.</clue>
</event>
<event id="E17">
<type class="Gene_expression" />
<theme idref="T19" />
<clue>Addition of rIL-2 fully restored the proliferative response and partially restored the <clueType>production</clueType> of IL-4 and IL-5, but not that <linkTheme>of</linkTheme> other cytokines.</clue>
<comment>NER T19 MOD, CAUTION: that = production</comment>
</event>
<event id="E18">
<type class="Positive_regulation" />
<theme idref="E15" />
<cause idref="T16" />
<clue><linkCause>Addition of</linkCause> rIL-2 fully restored the proliferative response and partially <clueType>restored</clueType> the production of IL-4 and IL-5, but not that of other cytokines.</clue>
</event>
<event id="E19">
<type class="Positive_regulation" />
<theme idref="E16" />
<cause idref="T16" />
<clue><linkCause>Addition of</linkCause> rIL-2 fully restored the proliferative response and partially <clueType>restored</clueType> the production of IL-4 and IL-5, but not that of other cytokines.</clue>
</event>
<event assertion="non-exist" id="E20">
<type class="Positive_regulation" />
<theme idref="E17" />
<cause idref="T16" />
<clue><linkCause>Addition of</linkCause> rIL-2 fully restored the proliferative response and partially <clueType>restored</clueType> the production of IL-4 and IL-5, but not that of other cytokines.</clue>
</event>
<sentence id="S5">In contrast, in <term sem="Cell_natural" id="A2">cells</term> stimulated with <term sem="Organic_compound_other" id="T20" lex="phorbol_myristate_acetate">phorbol myristate acetate</term> (<term sem="Organic_compound_other" id="T22" lex="PMA">PMA</term>)/<term sem="Organic_compound_other" id="T23" lex="A23187">A23187</term>, <term sem="Lipid" id="T24" lex="PGE2">PGE2</term> enhanced the production of <term sem="Protein_molecule" id="T25" lex="IL-4">IL-4</term> and <term sem="Protein_molecule" id="T26" lex="IL-5">IL-5</term>, and only partially inhibited the production of <term sem="Protein_family_or_group" id="T27" lex="cytokine">other cytokines</term>.</sentence>
<event id="E21">
<type class="Physiological_process" />
<theme idref="A2" />
<cause idref="T22" />
<cause idref="T23" />
<clue>In contrast, in cells <clueType>stimulated</clueType> <linkCause>with</linkCause> phorbol myristate acetate (PMA)/A23187, PGE2 enhanced the production of IL-4 and IL-5, and only partially inhibited the production of other cytokines.</clue>
<comment>NER T24 MOD, T21 DEL</comment>
</event>
<event id="E22">
<type class="Gene_expression" />
<theme idref="T25" />
<clue>In contrast, in cells stimulated with phorbol myristate acetate (PMA)/A23187, PGE2 enhanced the <clueType>production</clueType> <linkTheme>of</linkTheme> IL-4 and IL-5, and only partially inhibited the production of other cytokines.</clue>
</event>
<event id="E23">
<type class="Gene_expression" />
<theme idref="T26" />
<clue>In contrast, in cells stimulated with phorbol myristate acetate (PMA)/A23187, PGE2 enhanced the <clueType>production</clueType> <linkTheme>of</linkTheme> IL-4 and IL-5, and only partially inhibited the production of other cytokines.</clue>
</event>
<event id="E24">
<type class="Positive_regulation" />
<theme idref="E22" />
<cause idref="T24" />
<clue>In contrast, in cells stimulated with phorbol myristate acetate (PMA)/A23187, PGE2 <clueType>enhanced</clueType> the production of IL-4 and IL-5, and only partially inhibited the production of other cytokines.</clue>
</event>
<event id="E25">
<type class="Positive_regulation" />
<theme idref="E23" />
<cause idref="T24" />
<clue>In contrast, in cells stimulated with phorbol myristate acetate (PMA)/A23187, PGE2 <clueType>enhanced</clueType> the production of IL-4 and IL-5, and only partially inhibited the production of other cytokines.</clue>
</event>
<event id="E26">
<type class="Gene_expression" />
<theme idref="T27" />
<clue>In contrast, in cells stimulated with phorbol myristate acetate (PMA)/A23187, PGE2 enhanced the production of IL-4 and IL-5, and only partially inhibited the <clueType>production</clueType> of other cytokines.</clue>
<comment>NER T27 MOD</comment>
</event>
<event id="E27">
<type class="Negative_regulation" />
<theme idref="E26" />
<cause idref="T24" />
<clue>In contrast, <clueLoc>in cells stimulated with phorbol myristate acetate (PMA)/A23187</clueLoc>, PGE2 enhanced the production of IL-4 and IL-5, and only partially <clueType>inhibited</clueType> the production of other cytokines.</clue>
</event>
<sentence id="S6">Therefore, the effects of <term sem="Lipid" id="T28" lex="PGE2">PGE2</term> vary depending on the mode of <term sem="Other" id="T29" lex="T_cell_activation"><term sem="Cell_natural" id="A3">T cell</term> activation</term>, and the <term sem="Protein_molecule" id="T30" lex="IL-4">IL-4</term> and <term sem="Protein_molecule" id="T31" lex="IL-5">IL-5</term> are regulated differently from <term sem="Protein_family_or_group" id="T32" lex="cytokine">other cytokines</term>.</sentence>
<event id="E28">
<type class="Physiological_process" />
<theme idref="A3" />
<clue>Therefore, the effects of PGE2 vary depending on the mode of T cell <clueType>activation</clueType>, and the IL-4 and IL-5 are regulated differently from other cytokines.</clue>
<comment>NER T28 MOD</comment>
</event>
<event id="E29">
<type class="Regulation" />
<cause idref="T28" />
<clue>Therefore, the <clueType>effects</clueType> <linkCause>of</linkCause> PGE2 vary depending on the mode of T cell activation, and the IL-4 and IL-5 are regulated differently from other cytokines.</clue>
</event>
<event id="E30">
<type class="Regulation" />
<theme idref="E29" />
<cause idref="E28" />
<clue>Therefore, the effects of PGE2 <clueType>vary</clueType> <linkCause>depending on</linkCause> the mode of T cell activation, and the IL-4 and IL-5 are regulated differently from other cytokines.</clue>
</event>
<event id="E31">
<type class="Regulation" />
<theme idref="T30" />
<cause idref="T28" />
<clue>Therefore, the effects of PGE2 vary depending on the mode of T cell activation, and the IL-4 and IL-5 are <clueType>regulated</clueType> differently from other cytokines.</clue>
<comment>NO COREFCAUSE</comment>
</event>
<event id="E32">
<type class="Regulation" />
<theme idref="T31" />
<cause idref="T28" />
<clue>Therefore, the effects of PGE2 vary depending on the mode of T cell activation, and the IL-4 and IL-5 are <clueType>regulated</clueType> differently from other cytokines.</clue>
<comment>NO COREFCAUSE</comment>
</event>
<event id="E33">
<type class="Regulation" />
<theme idref="T32" />
<cause idref="T28" />
<clue>Therefore, the effects of PGE2 vary depending on the mode of T cell activation, and the IL-4 and IL-5 are <clueType>regulated</clueType> <linkTheme>differently from</linkTheme> other cytokines.</clue>
<comment>NER T32 MOD</comment>
</event>
<sentence id="S7">In a <term sem="Other" id="T33" lex="mobility_shift_assay">mobility shift assay</term>, only the <term sem="Protein_complex" id="T34" lex="NF-kappa_B_(p50/p50)_homodimer">NF-kappa B (<term sem="Protein_molecule" id="T36" lex="p50">p50</term>/<term sem="Protein_molecule" id="T37" lex="p50">p50</term>) homodimer</term> was observed in a complex formed with the <term sem="DNA_domain_or_region" id="T38" lex="kappa_B_sequence">kappa B sequence</term> in <term sem="Cell_natural" id="A4">unstimulated SP-B21 cells</term>.</sentence>
<event id="E34">
<type class="Binding" />
<theme idref="T34" />
<theme idref="T38" />
<clue><clueExperiment>In a mobility shift assay</clueExperiment>, only the NF-kappa B (p50/p50) homodimer was observed in a <clueType>complex formed</clueType> <linkTheme>with</linkTheme> the kappa B sequence <clueLoc>in unstimulated SP-B21 cells</clueLoc>.</clue>
<comment>NER T34,T37 MOD, T35 DEL</comment>
</event>
<sentence id="S8">When <term sem="Cell_natural" id="A6">cells</term> were stimulated with <term sem="Protein_family_or_group" id="T39" lex="anti-CD3_mAb">anti-CD3 mAb</term> or <term sem="Organic_compound_other" id="T40" lex="PMA">PMA</term>/<term sem="Organic_compound_other" id="T41" lex="A23187">A23187</term>, a complex formation of <term sem="Protein_complex" id="A5">NF-kappa B (<term sem="Protein_molecule" id="T43" lex="p50">p50</term>/<term sem="Protein_molecule" id="T44" lex="p65">p65</term>) heterodimer</term> with the <term sem="DNA_domain_or_region" id="T45" lex="kappa_B_sequence">kappa B sequence</term> was induced.</sentence>
<event id="E35">
<type class="Physiological_process" />
<theme idref="A6" />
<cause idref="T39" />
<clue>When cells were <clueType>stimulated</clueType> <linkCause>with</linkCause> anti-CD3 mAb or PMA/A23187, a complex formation of NF-kappa B (p50/p65) heterodimer with the kappa B sequence was induced.</clue>
<comment>NER T39,T41 MOD, T42 DEL</comment>
</event>
<event id="E36">
<type class="Physiological_process" />
<theme idref="A6" />
<cause idref="T40" />
<cause idref="T41" />
<clue>When cells were <clueType>stimulated</clueType> <linkCause>with</linkCause> anti-CD3 mAb or PMA/A23187, a complex formation of NF-kappa B (p50/p65) heterodimer with the kappa B sequence was induced.</clue>
</event>
<event id="E37">
<type class="Binding" />
<theme idref="A5" />
<theme idref="T45" />
<clue>When cells were stimulated with anti-CD3 mAb or PMA/A23187, a <clueType>complex formation</clueType> <linkTheme>of</linkTheme> NF-kappa B (p50/p65) heterodimer <linkTheme>with</linkTheme> the kappa B sequence was induced.</clue>
</event>
<event id="E38">
<type class="Positive_regulation" />
<theme idref="E37" />
<cause idref="E35" />
<clue><linkCause>When</linkCause> cells were stimulated with anti-CD3 mAb or PMA/A23187, a complex formation of NF-kappa B (p50/p65) heterodimer with the kappa B sequence was <clueType>induced</clueType>.</clue>
</event>
<event id="E39">
<type class="Positive_regulation" />
<theme idref="E37" />
<cause idref="E36" />
<clue><linkCause>When</linkCause> cells were stimulated with anti-CD3 mAb or PMA/A23187, a complex formation of NF-kappa B (p50/p65) heterodimer with the kappa B sequence was <clueType>induced</clueType>.</clue>
</event>
<sentence id="S9">Interestingly, <term sem="Lipid" id="T46" lex="PGE2">PGE2</term> or <term sem="Nucleotide" id="T47" lex="di-butyryl_(Bt2)cAMP">di-butyryl (Bt2)<term sem="Nucleotide" id="T48" lex="cAMP">cAMP</term></term> abolished the binding of <term sem="Protein_complex" id="T49" lex="NF-kappa_B_(p50/p65)_heterodimer">NF-kappa B (<term sem="Protein_molecule" id="T51" lex="p50">p50</term>/<term sem="Protein_molecule" id="T52" lex="p65">p65</term>) heterodimer</term> to the <term sem="DNA_domain_or_region" id="T53" lex="kappa_B_sequence">kappa B sequence</term> in <term sem="Cell_natural" id="A7">cells</term> stimulated with <term sem="Protein_molecule" id="T54" lex="anti-CD3_mAb">anti-CD3 mAb</term> but not with <term sem="Organic_compound_other" id="T56" lex="PMA">PMA</term>/<term sem="Organic_compound_other" id="T57" lex="A23187">A23187</term>.</sentence>
<event id="E40">
<type class="Binding" />
<theme idref="T49" />
<theme idref="T53" />
<clue>Interestingly, PGE2 or di-butyryl (Bt2)cAMP abolished the <clueType>binding</clueType> <linkTheme>of</linkTheme> NF-kappa B (p50/p65) heterodimer to the kappa B sequence in cells stimulated with anti-CD3 mAb but not with PMA/A23187.</clue>
<comment>NER T46,T52,T57 MOD, T50,T55 DEL</comment>
</event>
<event id="E41">
<type class="Negative_regulation" />
<theme idref="E40" />
<cause idref="T46" />
<clue>Interestingly, PGE2 or di-butyryl (Bt2)cAMP <clueType>abolished</clueType> the binding of NF-kappa B (p50/p65) heterodimer to the kappa B sequence <clueLoc>in cells stimulated with anti-CD3 mAb</clueLoc> but not with PMA/A23187.</clue>
</event>
<event id="E42">
<type class="Negative_regulation" />
<theme idref="E40" />
<cause idref="T47" />
<clue>Interestingly, PGE2 or di-butyryl (Bt2)cAMP <clueType>abolished</clueType> the binding of NF-kappa B (p50/p65) heterodimer to the kappa B sequence <clueLoc>in cells stimulated with anti-CD3 mAb</clueLoc> but not with PMA/A23187.</clue>
</event>
<event assertion="non-exist" id="E43">
<type class="Negative_regulation" />
<theme idref="E40" />
<cause idref="T46" />
<clue>Interestingly, PGE2 or di-butyryl (Bt2)cAMP <clueType>abolished</clueType> the binding of NF-kappa B (p50/p65) heterodimer to the kappa B sequence <clueLoc>in cells stimulated</clueLoc> with anti-CD3 mAb but not <clueLoc>with PMA/A23187</clueLoc>.</clue>
</event>
<event assertion="non-exist" id="E44">
<type class="Negative_regulation" />
<theme idref="E40" />
<cause idref="T47" />
<clue>Interestingly, PGE2 or di-butyryl (Bt2)cAMP <clueType>abolished</clueType> the binding of NF-kappa B (p50/p65) heterodimer to the kappa B sequence <clueLoc>in cells stimulated</clueLoc> with anti-CD3 mAb but not <clueLoc>with PMA/A23187</clueLoc>.</clue>
</event>
<event id="E45">
<type class="Physiological_process" />
<theme idref="A7" />
<cause idref="T54" />
<clue>Interestingly, PGE2 or di-butyryl (Bt2)cAMP abolished the binding of NF-kappa B (p50/p65) heterodimer to the kappa B sequence in cells <clueType>stimulated</clueType> <linkCause>with</linkCause> anti-CD3 mAb but not with PMA/A23187.</clue>
</event>
<event id="E46">
<type class="Physiological_process" />
<theme idref="A7" />
<cause idref="T56" />
<cause idref="T57" />
<clue>Interestingly, PGE2 or di-butyryl (Bt2)cAMP abolished the binding of NF-kappa B (p50/p65) heterodimer to the kappa B sequence in cells <clueType>stimulated</clueType> with anti-CD3 mAb but not <linkCause>with</linkCause> PMA/A23187.</clue>
</event>
<sentence id="S10">Our results suggest that the target of <term sem="Other" id="T58" lex="PGE2_action"><term sem="Lipid" id="T59" lex="PGE2">PGE2</term> action</term> is a <term sem="Protein_family_or_group" id="A8">component</term> in the <term sem="Other" id="A9">signal transduction pathway</term> leading to the activation of <term sem="Protein_molecule" id="T60" lex="protein_kinase_C">protein kinase C</term>.</sentence>
<event uncertainty="probable" id="E47">
<type class="Regulation" />
<theme idref="A8" />
<cause idref="T59" />
<clue>Our results suggest that the <clueType>target</clueType> <linkCause>of</linkCause> PGE2 action is a component in the signal transduction pathway leading to the activation of protein kinase C.</clue>
</event>
<event id="E48">
<type class="Positive_regulation" />
<theme idref="T60" />
<clue>Our results suggest that the target of PGE2 action is a component in the signal transduction pathway leading to the <clueType>activation</clueType> <linkTheme>of</linkTheme> protein kinase C.</clue>
</event>
<event id="E49">
<type class="Positive_regulation" />
<theme idref="E48" />
<cause idref="A9" />
<clue>Our results suggest that the target of PGE2 action is a component in the signal transduction pathway <clueType>leading</clueType> <linkTheme>to</linkTheme> the activation of protein kinase C.</clue>
</event>
<event id="E50">
<type class="Correlation" />
<theme idref="A8" />
<theme idref="E49" />
<clue>Our results suggest that the target of PGE2 action is a component <clueType>in</clueType> the signal transduction pathway leading to the activation of protein kinase C.</clue>
</event>
<sentence id="S11">However, the inhibition of the <term sem="Other" id="T61" lex="T_cell_activation"><term sem="Cell_natural" id="A10">T cell</term> activation</term> signals by <term sem="Lipid" id="T62" lex="PGE2">PGE2</term> is selective.</sentence>
<event id="E51">
<type class="Physiological_process" />
<theme idref="A10" />
<clue>However, the inhibition of the T cell <clueType>activation signals</clueType> by PGE2 is selective.</clue>
</event>
<event id="E52">
<type class="Negative_regulation" />
<theme idref="E51" />
<cause idref="T62" />
<clue>However, the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> the T cell activation signals <linkCause>by</linkCause> PGE2 is selective.</clue>
</event>
<sentence id="S12"><term sem="Lipid" id="T63" lex="PGE2">PGE2</term> enhanced the complex formation with <cons sem="(AND DNA_domain_or_region DNA_domain_or_region DNA_domain_or_region)" id="T64" lex="(AND NF-AT_sequence AP-1_sequence CLE0_sequence)"><frag id="F1"><term sem="DNA_domain_or_region" id="A11">NF-AT</term></frag>, <frag id="F2"><term sem="DNA_domain_or_region" id="A12">AP-1</term></frag> and <frag id="F3"><term sem="DNA_domain_or_region" id="A13">CLE0</term></frag> <frag id="F4"><term sem="DNA_domain_or_region" id="A14">sequences</term></frag></cons> when the <term sem="Cell_natural" id="A15">cells</term> were activated by either <term sem="Protein_molecule" id="T65" lex="anti-CD3_mAb">anti-CD3 mAb</term> or <term sem="Other" id="T66" lex="PMA/A23187_stimulation"><term sem="Organic_compound_other" id="T67" lex="PMA">PMA</term>/<term sem="Organic_compound_other" id="T68" lex="A23187">A23187</term> stimulation</term>.</sentence>
<event id="E53">
<type class="Binding" />
<theme idref1="A14" idref="A11" />
<clue>PGE2 enhanced the <clueType>complex formation</clueType> <linkTheme>with</linkTheme> NF-AT, AP-1 and CLE0 sequences when the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
<comment>NER T63,T68 MOD</comment>
</event>
<event id="E54">
<type class="Binding" />
<theme idref1="A14" idref="A12" />
<clue>PGE2 enhanced the <clueType>complex formation</clueType> <linkTheme>with</linkTheme> NF-AT, AP-1 and CLE0 sequences when the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E55">
<type class="Binding" />
<theme idref1="A14" idref="A13" />
<clue>PGE2 enhanced the <clueType>complex formation</clueType> <linkTheme>with</linkTheme> NF-AT, AP-1 and CLE0 sequences when the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E56">
<type class="Positive_regulation" />
<theme idref="E53" />
<cause idref="T63" />
<cause idref="E59" />
<clue>PGE2 <clueType>enhanced</clueType> the complex formation with NF-AT, AP-1 and CLE0 sequences <linkCause>when</linkCause> the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E61">
<type class="Positive_regulation" />
<theme idref="E53" />
<cause idref="T63" />
<cause idref="E60" />
<clue>PGE2 <clueType>enhanced</clueType> the complex formation with NF-AT, AP-1 and CLE0 sequences <linkCause>when</linkCause> the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E57">
<type class="Positive_regulation" />
<theme idref="E54" />
<cause idref="T63" />
<cause idref="E59" />
<clue>PGE2 <clueType>enhanced</clueType> the complex formation with NF-AT, AP-1 and CLE0 sequences <linkCause>when</linkCause> the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E62">
<type class="Positive_regulation" />
<theme idref="E54" />
<cause idref="T63" />
<cause idref="E60" />
<clue>PGE2 <clueType>enhanced</clueType> the complex formation with NF-AT, AP-1 and CLE0 sequences <linkCause>when</linkCause> the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E58">
<type class="Positive_regulation" />
<theme idref="E55" />
<cause idref="T63" />
<cause idref="E59" />
<clue>PGE2 <clueType>enhanced</clueType> the complex formation with NF-AT, AP-1 and CLE0 sequences <linkCause>when</linkCause> the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E63">
<type class="Positive_regulation" />
<theme idref="E55" />
<cause idref="T63" />
<cause idref="E60" />
<clue>PGE2 <clueType>enhanced</clueType> the complex formation with NF-AT, AP-1 and CLE0 sequences <linkCause>when</linkCause> the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E59">
<type class="Physiological_process" />
<theme idref="A15" />
<cause idref="T65" />
<clue>PGE2 enhanced the complex formation with NF-AT, AP-1 and CLE0 sequences when the cells were <clueType>activated</clueType> <linkCause>by</linkCause> either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E60">
<type class="Physiological_process" />
<theme idref="A15" />
<cause idref="T67" />
<cause idref="T68" />
<clue>PGE2 enhanced the complex formation with NF-AT, AP-1 and CLE0 sequences when the cells were <clueType>activated</clueType> <linkCause>by</linkCause> either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<sentence id="S13">It seems therefore that <term sem="Lipid" id="T69" lex="PGE2">PGE2</term>, by elevating <term sem="Other" id="T70" lex="cAMP_level"><term sem="Nucleotide" id="T71" lex="cAMP">cAMP</term> levels</term>, interferes with the activation pathway for <term sem="Protein_molecule" id="T72" lex="NF-kappa_B">NF-kappa B</term> but not for <term sem="Protein_molecule" id="T73" lex="NF-AT">NF-AT</term>, <term sem="Protein_molecule" id="T74" lex="AP-1">AP-1</term> or <term sem="Protein_molecule" id="T75" lex="CLE0_binding_protein">CLE0</term> <term sem="Protein_molecule" id="A16">binding protein</term>.</sentence>
<event id="E70">
<type class="Positive_regulation" />
<theme idref="T72" />
<clue>It seems therefore that PGE2, by elevating cAMP levels, interferes with the <clueType>activation pathway</clueType> <linkTheme>for</linkTheme> NF-kappa B but not for NF-AT, AP-1 or CLE0 binding protein.</clue>
<comment>NER T75 MOD</comment>
</event>
<event id="E71">
<type class="Positive_regulation" />
<theme idref1="A16" idref="T73" />
<clue>It seems therefore that PGE2, by elevating cAMP levels, interferes with the <clueType>activation pathway</clueType> for NF-kappa B but not <linkTheme>for</linkTheme> NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
<event id="E72">
<type class="Positive_regulation" />
<theme idref1="A16" idref="T74" />
<clue>It seems therefore that PGE2, by elevating cAMP levels, interferes with the <clueType>activation pathway</clueType> for NF-kappa B but not <linkTheme>for</linkTheme> NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
<event id="E64">
<type class="Positive_regulation" />
<theme idref1="A16" idref="T75" />
<clue>It seems therefore that PGE2, by elevating cAMP levels, interferes with the <clueType>activation pathway</clueType> for NF-kappa B but not <linkTheme>for</linkTheme> NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
<event id="E65">
<type class="Positive_regulation" />
<theme idref="T71" />
<cause idref="T65" />
<clue>It seems therefore that PGE2, by <clueType>elevating</clueType> cAMP <clueType>levels</clueType>, interferes with the activation pathway for NF-kappa B but not for NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
<event uncertainty="probable" id="E66">
<type class="Negative_regulation" />
<theme idref="E61" />
<cause idref="E65" />
<clue>It seems therefore that PGE2, <linkCause>by</linkCause> elevating cAMP levels, <clueType>interferes</clueType> with the activation pathway for NF-kappa B but not for NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
<event assertion="non-exist" uncertainty="probable" id="E67">
<type class="Negative_regulation" />
<theme idref="E62" />
<cause idref="E65" />
<clue>It seems therefore that PGE2, <linkCause>by</linkCause> elevating cAMP levels, <clueType>interferes</clueType> with the activation pathway for NF-kappa B but not for NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
<event assertion="non-exist" uncertainty="probable" id="E68">
<type class="Negative_regulation" />
<theme idref="E63" />
<cause idref="E65" />
<clue>It seems therefore that PGE2, <linkCause>by</linkCause> elevating cAMP levels, <clueType>interferes</clueType> with the activation pathway for NF-kappa B but not for NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
<event assertion="non-exist" uncertainty="probable" id="E69">
<type class="Negative_regulation" />
<theme idref="E64" />
<cause idref="E65" />
<clue>It seems therefore that PGE2, <linkCause>by</linkCause> elevating cAMP levels, <clueType>interferes</clueType> with the activation pathway for NF-kappa B but not for NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
